SUCCESSFULL PHARMACOVIGILANCE AUDIT

On 18 January Aicore Life Sciences was successfully audited by Intertek according to the EU Good Pharmacovigilance Practice (GVP) standards for medicinal products. No critical, major or minor deficiencies were found. Aicore Life Sciences markets and distributes a number of evidence-based prescription drugs and medical devices in East European countries. We are developing a product portfolio of both affordable generics and new chemical entities/dosage forms with an emphasis on women’s health. Our network encompasses the complete range of facilities required for all stages of drug development, distribution, marketing and sales across the European continent, and includes partnerships with academia.